Program

※Excerpt only international sessions

The following programs listed below are to take place physically on August 19-21 at PACIFICO YOKOHAMA, Annex Hall and North. The in-person meeting will be recorded and will be available online for the participants from the middle of September till early October.
*Live streaming service is not available.

Special Session "COVID-19 and kidney diseases -to conquer the COVID-19 pandemic"

Date: 13:30-15:30, August 19 (Wed)
Venue: Room1 (F201-204, Annex Hall 2F, PACIFICO YOKOHAMA)
Chairs: Naoki Kashihara (President of JSN / Kawasaki Medical School)
Masaomi Nangaku (President of APSN / The University of Tokyo)

1. Activities of the ASN during the COVID-19 pandemic
   Anupam Agarwal (President of ASN / University of Alabama at Birmingham)
   
2. Global nephrology during and after COVID
   Vivekanand Jha (President of ISN / George Institute for Global Health)
   
3. COVID-19 kidney disease research in Europe and in Germany
   Christoph Wanner (President of ERA-EDTA / University Hospital of Würzburg)
   
4. Combat against COVID-19 in Japan and Asia
   Masaomi Nangaku (President of APSN / The University of Tokyo)

Oshima Award Lecture

Date: 15:30-16:10, August 19 (Wed)
Venue: Room1 (F201-204, Annex Hall 2F, PACIFICO YOKOHAMA)
Chairs: Keiko Uchida (Tokyo Women's Medical University)
Masaomi Nangaku (The University of Tokyo)

1. Identification of Molecular Mechanisms for AQP2 Regulation and Development of Therapeutic Drugs for Congenital Nephrogenic Diabetes Insipidus
   Fumiaki Ando (Tokyo Medical and Dental University)
   
2. Neuro-immune systems-mediated renal protection mechanism
   Tsuyoshi Inoue (The University of Tokyo)

CSA (Clinical Scientist Award) Lecture

Date: 16:10-16:30, August 19 (Wed)
Venue: Room1 (F201-204, Annex Hall 2F, PACIFICO YOKOHAMA)
Chair: Masafumi Fukagawa (Tokai University)
"Clinical epidemiological cohort study to elucidate the pathophysiology of chronic kidney disease"
　　Shigeru Tanaka (Kyushu University)

Best Abstract Session (Regular submission)

Date: 9:00-12:00, August 21 (Fri)
Venue: Room4 (G316+G317, North 3F, PACIFICO YOKOHAMA)

Part 1. 9:00-9:30
Chairs: Reiko Inagi (The University of Tokyo)
　　　　Katsuhiko Asanuma (Chiba University)

1. 【O-002】Neutrophil EIF2AK2 promotes vascular adhesion and transmigration and regulates acute phase of inflammatory kidney disease
   Reiko Inoue (The University of Tokyo Hospital)
2. 【O-026】Activation of eNOS/sGC/PKG signaling pathway attenuates renal interstitial fibrosis via β-catenin degradation in mice
   Hiroyuki Kadoya (Kawasaki Medical School)
3. O-044 Regeneration of renal stroma using a progenitor cell replacement system
   Yatsumu Saito (The Jikei University School of Medicine)

Part 2. 9:30-9:50
Chairs: Akinori Hara (Kanazawa University)
　　　　Kumiko Torisu (Kyushu University)

1. 【O-191】A role of DNA repair factor KAT5 on ischemic preconditioning through regulation of chloride channel expression in proximal tubular cells
   Akihito Hishikawa (Keio University School of Medicine)
2. 【O-193】MicroRNA Expression profiling in Acute kidney injury
   Akinori Aomatsu (Jichi Medical University Saitama Medical Center)

Part 3. 9:50-10:10
Chairs: Junichi Hoshino (Toranomon Hospital)
　　　　Masaaki Nakayama (St. Luke’s International Hospital)

1. 【O-118】Cyclin G1 and TOR-autophagy spatial coupling compartments (TASCC) regulate pro-fibrotic secretory phenotypes in kidney tubule cells in the G2/M phase of the cell cycle Seiji Kishi (Kawasaki Medical School)
2. 【O-120】Glycan profile of acquired cystic disease associated renal cell carcinoma using lectin microarray systems
   Kunio Kawanishi (University of Tsukuba)

Part 4. 10:10-10:50
Chairs: Akihiro Tojo (Dokkyo University)
　　　　Satoko Nakamura (Kansai University of Welfare Sciences)

1. 【O-271】Renal water loss causes hypertension via water conservation of multiple organs in 5/6 nephrectomized rats
   Kento Kitada (Kagawa University)
2. 【O-281】Usefulness of Albuminuria beyond Blood Pressure as the Index of Cardiovascular Risk with Antihypertensive Drug Treatment
   Yawara Kikuchi (Iwate Medical University)
3. 【O-282】Blood pressure lowering effects and safety of esaxerenone, a newly available mineralocorticoid receptor blocker, in 234 hypertensive patients
   Fumitoshi Sato (Tohoku University Graduate School of Medicine)
4. 【O-206】Association between social background and mortality in patients with prevalent chronic hematodialysis
   Kumiko Aso (University of Miyazaki)

Part 5. 10:50-11:10
Chairs: Ritsuko Katafuchi (Kano Hospital)
　　　　Kazuhito Fukuoka (Kyorin University)

1. 【O-074】The effect of low-dose rituximab on immunosuppressive drugs dependent minimal change nephrotic syndrome
   Keiji Fujimoto (Kanazawa Medical University)
2. 【O-070】Contribution of Genetic Factors in Disease Progression of IgA nephropathy
   Yoshinori Sato (Showa University Fujigaoka Hospital)
3. 【O-083】Discovery of new biomarker and novel molecular pathogenesis of lupus nephritis
   Shin'ichi Akiyama (Naogya University)

Part 6. 11:10-12:00
Chairs: Keitaro Yokoyama (The Jikei University, Harumi Triton Clinic)
　　　　Mamiko Ohara (Kameda Medical Center)

1. 【O-253】Functional analysis of transmembrane SNPs of NBCe1
   Osamu Yamazaki (Teikyo University)
2. 【O-261】Fractures and antihypertensive drugs in patients with chronic kidney disease: the Fukuoka Kidney Registry
   Tomoya Shukuri (Fukuoka Red Cross Hospital)
3. 【O-256】Stimulatory effect of parathyroid hormone on renal gluconeogenesis in vivo
   Hiroyuki Tsukada (The University of Tokyo)

YIA (Young Investigator Award) Session

Date: 14:35-15:35, August 21 (Fri)
Venue: Room4 (G316+317, North 3F, PACIFICO YOKOHAMA)
Chair: Yoshio Terada (Kochi University)

1. Protein O-GlcNAcylation Is Essential for the Maintenance of Renal Energy Homeostasis and Function via Lipolysis during Fasting and Diabetes
   Sho Sugahara (Shiga University of Medical Science)
   
2. Prolyl hydroxylase domain inhibitor protects against metabolic disorders and associated kidney disease in obese type 2 diabetic mice
   Mai Sugahara (The University of Tokyo)
   
3. Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury
   Hiroshi Maekawa (The University of Tokyo)
   
4. Renal TNFα activates WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease
   Taisuke Furusho (Tokyo Medical and Dental University)